Tomas J. Heyman's Net Worth
$1.7 Million
Who is Tomas J. Heyman?
Tomas J. Heyman has an estimated net worth of $1.7 Million. This is based on reported shares across multiple companies, which include Adagio Therapeutics, Inc., OptiNose, Inc., Akero Therapeutics, Inc., Xilio Therapeutics, Inc., and EXELIXIS, INC..
SEC CIK
Tomas J. Heyman's CIK is 0001814673
Past Insider Trading and Trends
2023 was Tomas J. Heyman's most active year for acquiring shares with 7 total transactions. Tomas J. Heyman's most active month to acquire stocks was the month of May. 2023 was Tomas J. Heyman's most active year for disposing of shares, totalling 2 transactions. Tomas J. Heyman's most active month to dispose stocks was the month of May. 2023 saw Tomas J. Heyman paying a total of $651,040.00 for 212,229 shares, this is the most they've acquired in one year. In 2023 Tomas J. Heyman cashed out on 52,000 shares for a total of $1,421,529.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adagio Therapeutics, Inc. (IVVD) Snapshot price: $0.822
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OptiNose, Inc. (OPTN) Snapshot price: $0.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
$39.86 | -$770,489.20 |
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
| No matching records found | |||||||||
EXELIXIS, INC. (EXEL) Snapshot price: $25.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +103.64% | 18.84K |
—
|
—
| 37.01K |
May 31
| |||
Form 4
|
∞
| 18.18K |
—
|
—
| 18.18K |
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||